MyMD Pharmaceuticals, Inc. (MYMD) Financials
MYMD Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 21.8 million | 5.7 million |
2023-06-30 | 25.2 million | 14.5 million |
2023-03-31 | 28.4 million | 14.4 million |
2022-12-31 | 17.5 million | 2.8 million |
MYMD Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -3.2 million | 385143 |
2023-06-30 | -3.9 million | 1.0 million |
2023-03-31 | -4.0 million | 19908 |
2022-12-31 | -2.2 million | 45222 |
MYMD Net Income
No data available :(
MYMD Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 8.5 million | - | 93145 |
2023-06-30 | 11.6 million | - | 109792 |
2023-03-31 | 15.5 million | - | 126031 |
2022-12-31 | 4.8 million | - | 141721 |
MYMD Shares Outstanding
MYMD Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 1.9 million | 1.9 million | - |
2023-06-30 | - | 2.2 million | 3.6 million | - |
2023-03-31 | - | 770430 | 1.1 million | - |
2022-12-31 | - | 2.5 million | 1.3 million | - |
MYMD Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | - |
2023-06-30 | - | - |
2023-03-31 | - | - |
2022-12-31 | - | - |
MYMD
Price: $2.84
52 week price:
Earnings Per Share: -5.10 USD
P/E Ratio: -0.82
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 304100
Market Capitalization: 5.4 million